Results 21 to 30 of about 1,625,340 (281)
Factors affecting low fetal fraction in fetal screening with cell-free DNA in pregnant women: a systematic review and meta-analysis. [PDF]
Background Cell-Free DNA (cfDNA) is a non-invasive perinatal test (NIPT) used to assess fetal anomalies. The ability to detect fetal chromosomal aneuploidies is directly related to a sample’s fetal to total DNA fraction, known as the fetal fraction (FF).
Mousavi S +5 more
europepmc +2 more sources
FF-QuantSC: accurate quantification of fetal fraction by a neural network model. [PDF]
Background Noninvasive prenatal testing (NIPT) is one of the most commonly employed clinical measures for screening of fetal aneuploidy. Fetal Fraction (ff) has been demonstrated to be one of the key factors affecting the performance of NIPT.
Yuan Y +19 more
europepmc +2 more sources
Recently published international guidelines recommend the clinical use of noninvasive prenatal test (NIPT) for aneuploidy screening only among pregnant women whose fetuses are deemed at high risk.
Irena Hudecova +7 more
doaj +3 more sources
Association of fetal fraction with hypertensive disorders of pregnancy incidence and disease severity. [PDF]
Shree R +4 more
europepmc +2 more sources
Comparison of the Fetal Fraction of Cell-Free DNA in In-Vitro Fertilization (IVF) Versus Natural Conception Evaluation of the Fetal Fraction With IVF Parameters. [PDF]
Background As the offspring of assisted reproduction techniques (ARTs) have become a substantial proportion of the population, increased attention has been placed on the safety of ART. Investigators have focused on identifying a tool that combines molecular or biological tests that can predict the outcomes of in-vitro fertilization (IVF) or ...
Kallianidis K +7 more
europepmc +3 more sources
AbstractBackgroundFetal fraction (FF) measurement is considered important for reliable noninvasive prenatal testing (NIPT). Using minimal FF threshold as a quality parameter is under debate. We evaluated the variability in reported FFs of individual samples between providers and laboratories and within a single laboratory.MethodsGenomic quality ...
Ellis C Becking +11 more
openaire +5 more sources
The discovery of circulating fetal DNA in the plasma of pregnant women has greatly promoted advances in noninvasive prenatal testing. Screening performance is enhanced with higher fetal fraction and analysis of samples whose fetal DNA fraction is lower ...
Luca Bedon +5 more
doaj +1 more source
The effect of abnormal placentation on maternal serum fetal fraction of cell-free DNA
Abnormal placentation may affect the maternal serum fraction of cell-free fetal DNA (fetal fraction) determined as part of non-invasive prenatal screening (NIPS). This study aimed to assess whether the fetal fraction can predict placenta accreta spectrum
Rodriguez Marcella +5 more
doaj +1 more source
Fetal cell-free DNA fraction in maternal plasma is affected by fetal trisomy [PDF]
The purpose of this noninvasive prenatal testing (NIPT) study was to compare the fetal fraction of singleton gestations by gestational age, maternal characteristics and chromosome-specific aneuploidies as indicated by z-scores. This study was a multicenter prospective cohort study. Test data were collected from women who underwent NIPT by the massively
Nobuhiro, Suzumori +16 more
openaire +2 more sources
Cell-free DNA fetal fraction and preterm birth [PDF]
Cell-free deoxyribonucleic acid (DNA) is increasingly being used to screen for fetal aneuploidy. The majority of fetal cell-free DNA in the maternal blood results from release from the syncytiotrophoblast as a result of cellular apoptosis and necrosis.
Lorraine, Dugoff +5 more
openaire +2 more sources

